EcoBioTech

Polymeric and monomeric hydroxypropyl-β-cyclodextrin (HPCD) conjugates with human serum albumin (HSA) have been synthesized as a model system to modulate the pharmacokinetics and biodistribution of levofloxacin (LV). The structures of the synthesized materials have been confirmed by Fourier-transform infrared spectroscopy. Drug release studies showed that HSA–HPCD conjugate provided the most pronounced drug release retardation in comparison to free LV. In vivo have shown significant changes in the tissue distribution of the drug. Conjugated drugs increased LV accumulation in lung tissue from 5.4 to 8.7–9.7 μg/g, which is 1.6 to 1.8 times higher than the free drug. At the same time, antibiotic concentrations in liver decreased from 11.2 to 6.5–8.9 μg/g, and in kidney concentrations decreased from 13.4 to 6.3–6.4 μg/g, which is approximately a doubling reduction. In addition, conjugates maintained high blood LV concentrations throughout the entire observation period (480 min). These findings demonstrate the potential of this approach as a strategy to control the biodistribution of LV by modulation of the HSA antibiotic binding site.

β-cyclodextrin, levofloxacin, human serum albumin, pharmacokinetics, tissue distribution, conjugates

• Al Hagbani T., Vishwa B., Abu Lila A.S., Alotaibi H.F., Khafagy E.-S., Moin A., Gowda D. V. (2022) Pulmonary targeting of levofloxacin using microsphere-based dry powder inhalation. Pharmaceuticals. 15(5): 560. https://doi.org/10.3390/ph15050560 EDN: VUZOKI
• Ashraf S., Qaiser H., Tariq S., Khalid A., Makeen H.A., Alhazmi H.A., Ul-Haq Z. (2023) Unraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential. Current Research in Structural Biology. 6: 100114. https://doi.org/10.1016/j.crstbi.2023.100114 EDN: LBPIMP
• Biwer A., Antranikian G., Heinzle E. (2002) Enzymatic production of cyclodextrins. Applied Microbiology and Biotechnology. 59(6): 609–617. https://doi.org/10.1007/s00253-002-1057-x EDN: BDZOND
• Cao G., Zhu Y., Xie X., Chen Y., Yu J., Zhang J., Chen Z., Pang L., Zhang Y., Shi Y. (2020) Pharmacokinetics and pharmacodynamics of levofloxacin in bronchial mucosa and lung tissue of patients undergoing pulmonary operation. Experimental and Therapeutic Medicine. 20(1): 607–616. https://doi.org/10.3892/etm.2020.8715 EDN: YJEHQE
• Del Valle E.M.M. (2004) Cyclodextrins and their uses: A review. Process Biochemistry. 39(9): 1033–1046. https://doi.org/10.1016/S0032-9592(03)00258-9
• Dhiman P., Bhatia M. (2020) Pharmaceutical applications of cyclodextrins and their derivatives. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 98(3–4): 171–186. https://doi.org/10.1007/s10847-020-01029-3 EDN: ALQDBK
• Elsadek B., Kratz F. (2012) Impact of albumin on drug delivery — New applications on the horizon. Journal of Controlled Release. 157(1): 4–28. https://doi.org/10.1016/j.jconrel.2011.09.069
• Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. (2012) Human serum albumin: From bench to bedside. Molecular Aspects of Medicine. 33(3): 209–290. https://doi.org/10.1016/j.mam.2011.12.002 EDN: PHVLDH
• Fish D.N., Chow A.T. (1997) The clinical pharmacokinetics of levofloxacin. Clinical Pharmacokinetics. 32(2): 101–119. https://doi.org/10.2165/00003088-199732020-00002 EDN: YRLLJD
• Ghosh S., Paul B.K., Chattopadhyay N. (2014) Interaction of cyclodextrins with human and bovine serum albumins: A combined spectroscopic and computational investigation. Journal of Chemical Sciences. 126(4): 931–944. https://doi.org/10.1007/s12039-014-0652-6 EDN: UPYEKB
• Kopnova T.Y., Yakupova L.R., Belogurova N.G., Kudryashova E.V. (2024) Human serum albumin grafted by monomeric and polymeric β-cyclodextrin as drug delivery system for levofloxacin with improved pharmacological properties. Future Pharmacology. 4(1): 139–162. https://doi.org/10.3390/futurepharmacol4010010 EDN: IYHBFF
• Liu Z., Ye L., Xi J., Wang J., Feng Z. (2021) Cyclodextrin polymers: Structure, synthesis, and use as drug carriers. Progress in Polymer Science. 118: 101408. https://doi.org/10.1016/j.progpolymsci.2021.101408 EDN: TJCRUD
• Nafee N., Hirosue M., Loretz B., Wenz G., Lehr C.-M. (2015) Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin. Colloids and Surfaces B: Biointerfaces. 129: 30–38. https://doi.org/10.1016/j.colsurfb.2015.03.014
• Oi W., Isobe M., Hashidzume A., Harada A. (2011) Macromolecular recognition: Discrimination between human and bovine serum albumins by cyclodextrins. Macromolecular Rapid Communications. 32(6): 501–505. https://doi.org/10.1002/marc.201000699 EDN: OCCEWZ
• Seedher N., Agarwal P. (2010) Complexation of fluoroquinolone antibiotics with human serum albumin: A fluorescence quenching study. Journal of Luminescence. 130(10): 1841–1848. https://doi.org/10.1016/j.jlumin.2010.04.020 EDN: MYCAPL
• Shah S.R., Prajapati H.R., Sheth D.B., Gondaliya E.M., Vyas A.J., Soniwala M.M., Chavda J.R. (2020) Pharmacokinetics and in vivo distribution of optimized PLGA nanoparticles for pulmonary delivery of levofloxacin. Journal of Pharmacy and Pharmacology. 72(8): 1026–1037. https://doi.org/10.1111/jphp.13275 EDN: LEZTZB
• Skuredina A.A., Yakupova L.R., Kopnova T.Yu., Le-Deygen I.M., Belogurova N.G., Kudryashova E. V. (2023) Cyclodextrins and their polymers affect human serum albumin’s interaction with drugs used in the treatment of pulmonary infections. Pharmaceutics. 15(6): 1598. https://doi.org/10.3390/pharmaceutics15061598 EDN: WBINXO
• Spada A., Emami J., Tuszynski J.A., Lavasanifar A. (2021) The uniqueness of albumin as a carrier in nanodrug delivery. Molecular Pharmaceutics. 18(5): 1862–1894. https://doi.org/10.1021/acs.molpharmaceut.1c00046 EDN: LWAKVA
• Suárez D.F., Consuegra J., Trajano V.C., Gontijo S.M.L., Guimarães P.P.G., Cortés M.E., Denadai Â.L., Sinisterra R.D. (2014) Structural and thermodynamic characterization of doxycycline/β-cyclodextrin supramolecular complex and its bacterial membrane interactions. Colloids and Surfaces B: Biointerfaces. 118: 194–201. https://doi.org/10.1016/j.colsurfb.2014.01.028
• Sułkowska A. (2002) Interaction of drugs with bovine and human serum albumin. Journal of Molecular Structure. 614(1–3): 227–232. https://doi.org/10.1016/S0022-2860(02)00256-9 EDN: BBDVFN
• van’t Boveneind-Vrubleuskaya N., Seuruk T., van Hateren K., van der Laan T., Kosterink J.G.W., van der Werf T.S., van Soolingen D., van den Hof S., Skrahina A., Alffenaar J.-W.C. (2017) Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients. Antimicrobial Agents and Chemotherapy. 61(8). https://doi.org/10.1128/AAC.00343-17 EDN: XOHVKE
• Yakupova L.R., Skuredina A.A., Kopnova T.Yu., Kudryashova E. V. (2023a) In vitro biological properties of cyclodextrin-based polymers: Interaction with human serum albumin, red blood cells and bacteria. Polysaccharides. 4(4): 343–357. https://doi.org/10.3390/polysaccharides4040020 EDN: YMGLVW
• Yakupova L.R., Skuredina A.A., Markov P.O., Le-Deygen I.M., Kudryashova E. V. (2023b) Cyclodextrin polymers as a promising drug carriers for stabilization of meropenem solutions. Applied Sciences. 13(6): 3608. https://doi.org/10.3390/app13063608 EDN: DWXULP
• Zlotnikov I.D., Davydova M.P., Danilov M.R., Krylov S.S., Belogurova N.G., Kudryashova E. V. (2023a) Covalent conjugates of allylbenzenes and terpenoids as antibiotics enhancers with the function of prolonged action. Pharmaceuticals. 16(8): 1102. https://doi.org/10.3390/ph16081102 EDN: RDCJFY
• Zlotnikov I.D., Streltsov D.A., Belogurova N.G., Kudryashova E. V. (2023b) Chitosan or cyclodextrin grafted with oleic acid self-assemble into stabilized polymeric micelles with potential of drug carriers. Life. 13(2): 446. https://doi.org/10.3390/life13020446 EDN: CRITFM
• Zlotnikov I.D., Vigovskiy M.A., Davydova M.P., Danilov M.R., Dyachkova U.D., Grigorieva O.A., Kudryashova E. V. (2022) Mannosylated systems for targeted delivery of antibacterial drugs to activated macrophages. International Journal of Molecular Sciences. 23(24): 16144. https://doi.org/10.3390/ijms232416144 EDN: ROHSWS